Back to Search Start Over

The 'Great Debate' at Melanoma Bridge 2020: December, 5th, 2020

Authors :
Paolo A. Ascierto
Michael B. Atkins
Alexander M. Eggermont
Jeffrey E. Gershenwald
Jean-Jacques Grob
Omid Hamid
Vernon K. Sondak
Jeffrey A. Sosman
Hussein A. Tawbi
Jeffrey S. Weber
Corrado Caracò
Iman Osman
Igor Puzanov
Source :
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Publication Year :
2021
Publisher :
BMC, 2021.

Abstract

Abstract The Great Debate session at the 2020 Melanoma Bridge virtual congress (December 3rd–5th, Italy) featured counterpoint views from experts on five specific controversial issues in melanoma. The debates considered whether or not innate immunity is important in the response to cancer and immunotherapy, how useful are the revised American Joint Committee on Cancer (AJCC) classification for the staging of patients, the use of sentinel node biopsy for staging patients, the use of triplet combination of targeted therapy plus immunotherapy versus combined immunotherapy, and the respective benefits of neoadjuvant versus adjuvant therapy. As is usual with Bridge congresses, the debates were assigned by meeting Chairs and positions taken by experts during the debates may not have necessarily reflected their own personal opinion.

Details

Language :
English
ISSN :
14795876
Volume :
19
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Journal of Translational Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.6ed1cc2e48e427fb2e3f34087eb34fc
Document Type :
article
Full Text :
https://doi.org/10.1186/s12967-021-02808-3